XML 43 R15.htm IDEA: XBRL DOCUMENT v3.20.2
INVENTORIES
12 Months Ended
Aug. 31, 2020
Inventories [Abstract]  
INVENTORIES [Text Block]

8. INVENTORIES

The Company's inventories are comprised of the following balances as of August 31, 2020 and August 31, 2019:

  AUGUST 31, 2020 
      FAIR VALUE     
  CAPITALIZED COST   ADJUSTMENT   CARRY ING VALUE 
Plants in drying stage$2,036  $1,841  $3,877 
Dry cannabis           
   Available for packaging 13,124   7,808   20,932 
   Packaged inventory 3,707   1,956   5,663 
Flower and trim available for extraction 849   1,062   1,911 
Concentrated extract 13,252   6,130   19,382 
Formulated extracts           
   Available for packaging 1,097   384   1,481 
   Packaged inventory 1,045   226   1,271 
Packaging and supplies 11,848      11,848 
 $46,958  $19,407  $66,365 

 

  AUGUST 31, 2019 
      FAIR VALUE     
  CAPITALIZED COST   ADJUSTMENT   CARRY ING VALUE 
Plants in drying stage$1,945  $4,256  $6,201 
Dry cannabis           
   Available for packaging 5,261   12,718   17,979 
   Packaged inventory 4,205   2,549   6,754 
Flower and trim available for extraction 4,433   12,193   16,626 
Concentrated extract 15,393   21,573   36,966 
Formulated extracts           
   Available for packaging 754   1,121   1,875 
   Packaged inventory 728   425   1,153 
Packaging and supplies 5,590      5,590 
 $38,309  $54,835  $93,144 

 

Flower and trim available for extraction are converted into concentrated extract, which can then be used for oil formulation (combining with a carrier oil) or other products such as edibles, and beverage and vaporizable products.

The amount of inventory expensed in cost of sales for the year ended August 31, 2020 was $42,872 (August 31, 2019 - $35,224). The amount of inventory write-down, provision, and plant waste included in cost of sales for the year ended August 31, 2020 was $45,270 (August 31, 2019 - $4,733), which relates to the production or purchase costs of these inventories and biological assets (refer to Note 7 for the write-down and provisions against the fair value component of these inventories).

Inventory write-down and provision relating to excess and unsaleable inventories for the year ended August 31, 2020 was $32,831 (August 31, 2019 - $744), of which $20,251 (August 31, 2019 - $nil) related to concentrated extract and flower and trim available for extraction.  Inventory write-down related to adjustments to net realizable value during the year ended August 31, 2020 was $2,753 (August 31, 2019 - $nil).  Inventory write-offs for the year ended August 31, 2020 related to abnormal plant waste due to lack of sufficient staffing as a result of COVID-19 was $5,048 (August 31, 2019 - $nil).